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I. INTRODUCTION
Genome editing, also referred to as “gene editing” or “gene therapy,” is
no longer a theoretical eventuality of scientific progression; it is a reality
of modern life. One of the numerous groups affected by this technology
is athletes as “gene doping” becomes a more viable option to improve
athletic performance each year. Some international agencies have begun
to address the issues presented by gene doping, but there is no comprehensive
international framework or regulations on the proper standards of use or
punishment for those who abuse this new technology. International agencies
must work together to establish regulations for human genome experiments
and gene doping while these technologies are still in the infancy of their
development. While unregulated, these technologies are dangerous and
ripe for misuse. Without appropriate regulations, future controversies
surrounding the misuse of genome editing can halt the growth of this
powerful technology. The proper regulations must be set immediately, not
to prevent the development of human genome therapy, but to ensure the
safe and ethical progression of this technology.
II. BACKGROUND
A. International Doping Regulations
Before examining current international gene doping regulations, it is
important to understand the agencies that developed the current international
doping framework. Doping has been a longstanding issue in international
sports, especially at the Olympic level. The International Olympic Committee
(“IOC”) was created in 1894 for the purpose of running and regulating the
Olympic Movement.1 While the IOC is seen as the leader of the Olympic
1. The Olympic Movement was founded by Pierre de Coubertin and encompasses
the Olympic Games as well as all the constituents of the event, including but not limited
to: the International Olympic Committee, the International Sports Federations, and the
National Olympic Committees. International Olympic Committee, OLYMPICS, https://olympics.
com/ioc/overview [https://perma.cc/C8L5-XPJ6]; Olympic Movement, OLYMPICS, https://
olympics.com/ioc/olympic-movement [https://perma.cc/5BF6-S6ET]; Pierre de Coubertin,
OLYMPICS, https://olympics.com/ioc/pierre-de-coubertin [https://perma.cc/C7Y8-HYFG].
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Movement, it also coordinates with International Sports Federations (“IFs”)
and National Olympic Committees (“NOCs”) to ensure the quadrennial
Olympic Games event and to promote Olympic values.2 The IOC derives
its authority through the Olympic Charter and its mission is “to protect
clean athletes and the integrity of sport, by leading the fight against doping,
and by taking action against all forms of manipulation of competitions and
related corruption.”3
The IOC recognized the need for an independent anti-doping agency
after the doping scandal at the 1998 Tour de France caused an international
controversy.4 As a result, the IOC held an international conference which
led to the development of the Lausanne Declaration on Doping in Sport.5
This declaration created the World Anti-Doping Agency (“WADA”) to
help combat the issue of doping in international sports.6 WADA’s core
activities are “scientific research, education, development of anti-doping
capacities, and monitoring of the World Anti-Doping Code – the document
harmonizing anti-doping policies in all sports and all countries.”7 The
highest policy-making body within WADA is its thirty-eight member
Foundation Board.8 This board has an equal number of IOC representatives
and representatives of national governments.9 WADA delegates its work
to National Anti-Doping Organizations (“NADOs”) within individual

2. These Olympic values include excellence, respect, and friendship. IOC Principles,
OLYMPICS, https://olympics.com/ioc/principles [https://perma.cc/35Z8-CMRC]; see also
Olympic Charter 9, 11, INT’L OLYMPIC COMM. (July 2020), https://stillmed.olympics.com/media/
Document%20Library/OlympicOrg/General/EN-Olympic-Charter.pdf?_ga=2.55413923.
96033511.1630354196-2121199226.1630354196 [https://perma.cc/8ZYJ-WY6M].
3. Olympic Charter, INT’L OLYMPIC COMM. 20 (July 2020), https://stillmed.olympics.
com/media/Document%20Library/OlympicOrg/General/EN-Olympic-Charter.pdf?_ga=
2.55413923.96033511.1630354196-2121199226.1630354196 [https://perma.cc/8ZYJ-WY6M].
4. Who We Are, WORLD ANTI-DOPING AGENCY , https://www.wada-ama.org/en/
who-we-are [https://perma.cc/C48Y-7VDH] [hereinafter WORLD ANTI-DOPING AGENCY];
Jeremy Whittle, The 1998 Tour de France: Police Raids, Arrests, Protests. . . and a Bike
Race, CYCLINGNEWS (Mar. 3, 2017), https://www.cyclingnews.com/features/the-1998tour-de-france-police-raids-arrests-protests-and-a-bike-race/ [https://perma.cc/2QNT-YV52].
5. WORLD ANTI-DOPING AGENCY, supra note 4.
6. WORLD ANTI-DOPING AGENCY, supra note 4.
7. WORLD ANTI-DOPING AGENCY, supra note 4.
8. Governance, WORLD ANTI-DOPING AGENCY, https://www.wada-ama.org/en/
governance [https://perma.cc/984A-ZG4Y].
9. Members are appointed by their respective constituency groups, such as: Africa
representatives, the Americas representatives, Asia representatives, Oceania representatives,
etc. Foundation Board, WORLD ANTI-DOPING AGENCY, https://www.wada-ama.org/en/
foundation-board [https://perma.cc/HHB8-3LDN].
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nations and ensures these NADOs are in compliance with the World AntiDoping Code.10 WADA and IOC still have close ties to this day; many of
those who hold leadership positions within WADA also hold leadership
positions within IOC.11
B. Olympic Doping Scandals
Since the modern Olympic games were revived, there have been numerous
Olympic doping scandals.12 These doping scandals have stained the public
opinion of WADA and IOC as the premier doping regulatory agencies
despite the current doping framework in place.13 A recent and noteworthy
Olympic doping scandal was the Russian state-sponsored doping scandal
which was uncovered in 2014.14 What makes this scandal noteworthy was
the difficulty that IOC and WADA had when trying to determine the
proper course of action and the proper punishment for the offenders.
WADA investigated the controversy in 2014 and released a two-part
document detailing their findings which implicated more than 1,000 Russian
athletes going back as far as 2011.15 In response to this report, WADA
called for a “blanket-ban” on all Russian athletes for the 2016 Rio Olympics,
however, IOC rejected this suggestion and instead allowed the athletes
respective IFs to determine eligibility.16 After the 2016 Olympics, IOC
announced its decision to ban Russia from the 2018 Winter Olympics

10. National Anti-Doping Organizations (NADO), WORLD ANTI-DOPING AGENCY
https://www.wada-ama.org/en/who-we-are/anti-doping-community/national-anti-dopingorganizations-nado [https://perma.cc/XJ7M-LQNT].
11. Rachel Axon, WADA Needs Better Governance, Experts Say IOC Set to Meet,
USA TODAY (Oct. 6, 2016, 6:42 PM), https://www.usatoday.com/story/olympics/2016/
10/06/wada-russian-doping-scandal-ioc/91691936/ [https://perma.cc/8TED-QUDH].
12. List of Olympic Games Scandals and Controversies, WIKIPEDIA, https://en.
wikipedia.org/wiki/List_of_Olympic_Games_scandals_and_controversies#2020_Summer
_Olympics_%E2%80%93_Tokyo,_Japan [https://perma.cc/538Y-YJMW].
13. See Rebecca R. Ruiz, Juliet Macur & Ian Austen, Even with Confession of Cheating,
World’s Doping Watchdog Did Nothing, N.Y. TIMES (June 15, 2016), https://www.nytimes.
com/2016/06/16/sports/olympics/world-anti-doping-agency-russia-cheating.html [https://
perma.cc/N4RY-L47S].
14. The Olympic Doping Dynasty, THE SPORTY LAWYER (July 25, 2020), https://
thesportylawyer.wordpress.com/2020/07/25/the-olympic-doping-dynasty/ [https://perma.cc/
K9QZ-9WVN].
15. Russian Doping: McLaren Report Says More Than 1,000 Athletes Implicated,
BBC (Dec. 9, 2016), https://www.bbc.com/sport/38261608 [https://perma.cc/SX79-ARGE].
16. Eoghan Macguire, Olympics: No Blanket Ban on Russian Athletes, IOC Says,
CNN (July 24, 2016), https://edition.cnn.com/2016/07/24/sport/russia-ioc-olympics-ban/
[https://perma.cc/EZN6-ER26].
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while still allowing certain Russian athletes not implicated in the scandal
to compete as “Olympic Athletes from Russia.”17
By 2019, WADA endorsed a recommendation made by the independent
Compliance Review Committee to impose a four-year “blanket-ban” on
Russian athletes from participating in any major international sporting
events unless they prove they were not implicated.18 This ban was due to
the country’s history of doping violations and non-compliance during
WADA’s investigation.19 IOC supported this decision after receiving much
backlash for rejecting WADA’s original “blanket-ban” proposal in 2016.20
C. Genome Editing/Gene Editing/Gene Therapy
Gene technologies are becoming more powerful and precise, making
their application in modern health situations more realistic. Genome editing
is a technology that allows scientists to change the DNA of an organism
to alter the physical traits of that organism, such as eye color or disease
risk.21 There are two main types of gene editing: somatic cell edits and
germline cell edits.22 Somatic gene therapies involve modifying a patient’s
DNA to treat or cure a disease caused by a genetic mutation and thus only
affect the patient being treated.23 Alternatively, germline gene therapies
alter the genome of an embryo at its earliest stages and can impact not
17. Rebecca Ruiz & Tariq Panja, Russia Banned from Winter Olympics by I.O.C.,
N.Y. TIMES (Dec. 5, 2017), https://www.nytimes.com/2017/12/05/sports/olympics/iocrussia-winter-olympics.html [https://perma.cc/RGL2-SV9G].
18. WADA Executive Committee Unanimously Endorses Four-Year Period of NonCompliance for the Russian Anti-Doping Agency, WORLD ANTI-DOPING AGENCY (Dec. 9,
2019), https://www.wada-ama.org/en/media/news/2019-12/wada-executive-committeeunanimously-endorses-four-year-period-of-non-compliance [https://perma.cc/4LCL-AC3Q].
19. Id.
20. Sean Ingle, Russia’s Athletes Escape Blanket IOC Ban for Rio Olympic Games,
GUARDIAN (July 24, 2016), https://www.theguardian.com/sport/2016/jul/24/russia-teamescape-blanket-ban-ioc-rio-olympic-games [https://perma.cc/8UE5-9YV3]; Statement
from the IOC on WADA Recommendation, OLYMPICS (Nov. 26, 2019), https://www.olympic.
org/news/statement-from-the-ioc-on-wada-recommendations [https://perma.cc/ZHU9-8WD8].
21. What is Genome Editing, NAT’L HUM. GENOME RSCH. INST. (Aug. 15, 2019),
https://www.genome.gov/about-genomics/policy-issues/what-is-Genome-Editing [https://
perma.cc/PTJ5-5XFM].
22. Mary Bergman, Perspectives on Gene Editing, THE HARV. GAZETTE (Jan. 9,
2019), https://news.harvard.edu/gazette/story/2019/01/perspectives-on-gene-editing/#:~:text=
Human%20genome%20editing%3A%20somatic%20vs.&text+While%20somatic%20ge
ne%20editing%20affects,passed%20on%20future%20generations [https://perma.cc/TN6CCURH].
23. Id.
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only the organism receiving the edits, but the organism’s offspring as
well.24 Somatic cell edits only change the targeted cells (if successful),
while germline cell edits affect all cells of the individual in question.25
One of the most rapidly evolving gene editing technologies is referred
to as “CRISPR-Cas9” (“CRISPR”). CRISPR is an acronym for “clusters
of regularly interspaced short palindromic repeats” which is a very
specialized stretch of DNA.26 It is through this specialized section of DNA
and the Cas9 enzyme that scientists have been able to “guide” edits to
the appropriate section of the genome.27
Although this technology allows for precision editing, preliminary
experiments have shown there is plenty of room for improvement.28 There
are long-term implications of this technology, such as possible mental and
physical health effects, that need more research.29 Subsequent studies have
shown that the CRISPR process turns off key anti-cancer mechanisms
within the targeted DNA.30 CRISPR may also result in “off-target” genetic
errors—unexpected deletions and scrambling of genetic code.31 As stated
by Dr. Greg Licholai, a lecturer at Yale School of Medicine and Chief
Medical and Information Officer at PRA Health Sciences, “[w]e think we
are editing one letter of the book of life, but . . . actually entire pages might
be getting altered in unintended areas.” 32 The previously mentioned
24. Id.
25. Britta C. van Beers, Rewriting the Human Genome, Rewriting Human Rights
Law? Human Rights, Human Dignity, and Human Germline Modification in the CRISPR
Era, 7 J.L. & BIOSCIENCES 1, 5 (June 9, 2020).
26. Aparna Vidyasagar, What is CRISPR?, LIVE SCIENCE (Apr. 21, 2018), https://
www.livescience.com/58790-crispr-explained.html [https://perma.cc/TBV5-V3HB].
27. This specialized section of DNA has two prominent characteristics: nucleotide
repeats and spacers. The nucleotide repeats are genetic information that can be modified,
while the spacers are “breaks” between the repeated sequences. Cas9 protein is an enzyme
that acts as a pair of molecular scissors able to slice DNA. This protein is bound with
CRISPR RNA which guides the Cas9 to the proper section of DNA. After the DNA helix
is sliced, the modified CRISPR nucleotide repeats are inserted. See id.
28. Of eighteen genome-edited embryos in Kathy Niakan’s CRISPR experiment,
twenty-two percent contained unwanted changes affecting large swathes of the DNA
surrounding the edited genome area. Heidi Ledford, CRISPR Editing Wreaks Chromosomal
Mayhem in Human Embroys, 583 NATURE 17, 18 (July 2, 2020), https://www.nature.
com/articles/d41586-020-01906-4 [https://perma.cc/7S46-8M9N].
29. Heidi Ledford, ‘CRISPR Babies’ are Still Too Risky, Says Influential Panel,
NATURE (Sept. 3, 2020) (online ahead of print), https://www.nature.com/articles/d41586020-02538-4 [https://perma.cc/7SWH-UFZA].
30. Daniel Oberhaus, DNA Damage from CRISPR Has Been ‘Seriously Underestimated’,
VICE (July 17, 2018), https://www.vice.com/amp/en/article/a3qv7a/dna-damage-fromcrispr-has-been-seriously-underestimated [https://perma.cc/5HKD-F6HZ].
31. Id.
32. Greg Licholai, Is CRISPR Worth the Risk?, YALE INSIGHTS (Aug. 21, 2018),
https://insights.som.yale.edu/insights/is-crispr-worth-the-risk#gref [https://perma.cc/A9MUQJ8A].
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deficiencies of CRISPR show that this process is still evolving, which is
leading to the development of new gene editing technologies.
A new gene therapy technique called Prime Editing (“Prime”) is
proving to be more accurate for exact DNA placement than its predecessor
CRISPR.33 Unlike CRISPR, Prime does not rely on the ability of a cell to
divide.34 Scientists can use Prime to target cells that CRISPR cannot, such
as nervous system cells.35 Prime also does not involve cutting both strands
of a DNA helix, thus mitigating the chances of unintended changes.36
These two gene therapy technologies exemplify the current power and
precision of gene editing; their progress suggests scientists will only continue
to develop even more precise gene technologies.
D. Gene Doping
Although there are many potentially positive health applications of gene
therapy, there also exists a potential for abuse of this technology in the
form of gene doping. Gene doping refers to “the non-therapeutic use of
genes, genetic elements and/or cells that have the capacity to enhance
athletic performance.”37 The allure of this type of doping is its potentially
undetectable nature.38 WADA included gene doping on its 2004 prohibition
list as a preemptive effort to stop this form of gene editing.39
Several genes have already been identified as potentially increasing
physical performance. In 1998, American scientist Lee Sweeney published a
study explaining his team’s success in increasing the muscle strength in

33. Rob Stein, Scientists Create New, More Powerful Technique to Edit Genes,
NPR (Oct. 21, 2019, 4:09 PM), https://www.npr.org/sections/health-shots/2019/10/21/77
1266879/scientists-create-new-more-powerful-technique-to-edit-genes [https://perma.cc/
4FHL-YEKG] [hereinafter Scientists Create].
34. Id.
35. Id.
36. Id.
37. World Anti-Doping Agency, The 2004 Prohibited List, International Standard,
Prohibited Methods: M3. Gene Doping, THE WORLD ANTI-DOPING CODE 1, 7 (Mar. 17,
2004), https://www.wada-ama.org/sites/default/files/resources/files/WADA_Prohibited_
List_2004_EN.pdf [https://perma.cc/6L6T-R5WG] [hereinafter 2004 Prohibited List].
38. Melinda Wenner, How to be Popular During the Olympics: Be H. Lee Sweeney,
Gene Doping Expert, S CI. AM . (Aug. 15, 2008), https://www.scientificamerican.com/
article/olympics-gene-doping-expert/ [https://perma.cc/5GPP-LKF6] [hereinafter Wenner].
39. Sarah Polcz & Anna Lewis, Regulating Genetic Advantage, 32 HARV. J.L. &
TECH. 266, 273, 290 (2018).
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mice by altering the IGF1 gene.40 Sweeney identified a possible genetic
doping method while attempting to solve the issue of muscular dystrophy.41
Since his discovery, Sweeney has been a major proponent for further
research of gene technologies, stating: “For me, gene doping will someday
be possible and a reality . . . . The phase that we are in now is when it is
potentially extremely dangerous.”42
Around the same time as Sweeney’s experiment, Philippe Moullier
published a study detailing how his team successfully introduced the
erythropoietin gene (“EPO”) to mice.43 Simply injecting EPO into one’s
bloodstream is both easily detectable and banned by WADA. 44 Like
Sweeney, Moullier’s goal was not to find new ways to improve athletic
performance, but rather to address a rare, genetic bone marrow issue.45 At
first it was unclear if this type of gene doping could be clearly detected,46
but in a subsequent study Moullier found that EPO made through a
recombinant hormone has a different isoelectric profile than naturally
occurring EPO; a difference easily detectible in urine.47 Likewise, there
have been other EPO gene modification detection methods that examine
the natural occurring EPO DNA sequence in athletes or look for the
existence of viruses typically used for genetic modification.48

40. IFG1 is the gene responsible for insulin-like growth factor one. Wenner, supra
note 38.
41. Leslie Pray, Sports, Gene Doping, and WADA, NATURE EDUCATION: SCITABLE
(2008), https://www.nature.com/scitable/topicpage/sports-gene-doping-and-wada-764/
[https://perma.cc/7YMT-KT63].
42. Fabian Filipp, Is Science Killing Sport? Gene Therapy and its Possible Abuse
in Doping, 8(5) EURO. MOLECULAR BIOLOGY ORG. 433, 435 (2007), https://www.ncbi.
nlm.nih.gov/pmc/articles/PMC1866212/pdf/7400968.pdf [https://perma.cc/MR3M-LKHU].
43. EPO is the hormone that controls the production of red blood cells. Tim Franks,
Gene Doping: Sport’s Biggest Battle?, BBC (Jan. 12, 2014), https://www.bbc.com/news/
magazine-25687002 [https://perma.cc/HT98-ZD5N]; Delphine Bohl, Anna Salvetti, Philippe
Moullier & Jean Michel Heard, Control of Erythropoietin Delivery by Doxycycline in Mice
After Intramuscular Injection of Adeno-Associated Vector, 92 BLOOD 1512, 1512 (Sept. 1,
1998), https://ashpublications.org/blood/article/92/5/1512/247395/Control-of-ErythropoietinDelivery-by-Doxycycline [https://perma.cc/KMQ4-Q2T5].
44. EPO Detection, WORLD ANTI-DOPING AGENCY, https://www.wada-ama.org/en/
questions-answers/epo-detection [https://perma.cc/4QNV-8MHY] [hereinafter EPO Detection].
45. See Franks, supra note 43.
46. Id.
47. Françoise Lasne et al., “Genetic Doping” With Erythropoientin cDNA in Primate
Muscle is Detectable, 10 MOLECULAR THERAPY 409 (Sept. 1, 2004), https://www.cell.com/
molecular-therapy-family/molecular-therapy/comments/S1525-0016(04)01358-9 [https://
perma.cc/AE3Y-FSTB].
48. Sarah Everts, New Tests to Identify Gene Tampering in Olympic Athletes, IN
CHEMISTRY (Oct. 10, 2016), https://inchemistry.acs.org/content/inchemistry/en/atomicnews/rio-doping.html [https://perma.cc/VXN2-CW3Y] (“Synthetic EPO DNA inserted
during gene therapy is unlikely to have [the natural occurring] intron sequence.”).
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Moreover, in 2004, Yong-Xu Wang, an associate professor at the
University of Massachusetts Medical School,49 published his study explaining
how he was able to inject mice with a gene that encodes a fat-burning
protein called PPARδ.50 The mice with the expressed gene were able to
run distances twice that of the control mice.51 Like those before him,
Wang was not performing his experiment with the hopes of increasing the
mice’s athletic performance, rather he was performing his experiment
with the hopes of combating type II diabetes.52 A previous study showed
that many of those suffering from type II diabetes have fewer type I muscle
fibers, giving Wang’s experiment possible therapeutic value.53
Since including gene doping on its prohibition list, WADA has taken
several steps to try to recognize and regulate doping at this level. They
designated an “expert group” tasked with studying the progress of genetic
editing and developing realistic detection methods.54 WADA took their
first athlete samples for genetic doping testing during the 2016 Rio Olympics,
but tests were not run during the games.55
In 2018, WADA considered requiring each Olympian to get their entire
genome sequenced—a type of “gene passport.” 56 This idea was not
implemented in full due to the cost restrictions of sequencing the human
genome at the time, but the price of sequencing the human genome has
only continued to drop with further technological advancement.57 WADA
already uses an “Athlete Biological Passport” (“ABP”) system for detecting
blood doping and steroids, with the first Athlete Biological Passport Operating
49. Molecular, Cell and Cancer Biology, UMASS CHAN MEDICAL SCHOOL, https://
umassmed.edu/mccb/faculty-MCCB/faculty-MCCB/faculty-profile-pages/wang/ [https://
perma.cc/ELK6-PSC8].
50. Yong-Xu Wang et al., Regulation of Muscle Fiber Type and Running Endurance by
PPARδ, 2 PLOS BIOLOGY 1532, 1532 (Aug. 24, 2004), https://journals.plos.org/plosbiology/
article?id=10.1371/journal.pbio.0020294 [https://perma.cc/TCM3-QCCG].
51. Id.
52. Id.
53. Pray, supra note 41.
54. Gene Doping, WORLD ANT-DOPING AGENCY, https://www.wada-ama.org/en/genedoping [https://perma.cc/S28N-T6LM].
55. Everts, supra note 48.
56. Eric Niiler, Olympics Could Require Athletes’ Genetic Code to Test For
Doping, WIRED, (Feb. 5, 2018, 7:00 AM), https://www.wired.com/story/olympics-couldrequire-athletes-genetic-code-to-test-for-doping/ [https://perma.cc/7TTE-YT9G].
57. Id.; The Cost of Sequencing a Human Genome, NAT’L HUM. GENOME RSCH.
INST. (Dec. 7, 2020), https://www.genome.gov/about-genomics/fact-sheets/SequencingHuman-Genome-cost#:~:text=The%20estimated%20cost%20for%20advancing,sequence
%20is%20~%24150%20million%20worldwide. [https://perma.cc/HVC9-4DQ4].
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Guidelines approved by WADA’s executive committee in 2009.58 WADA
collects samples of athlete’s blood and urine to determine the athlete’s
biological passport; this biological information is compared to later tests
to detect for doping.59
WADA took its first steps towards implementing an EPO gene doping
detection test when it collected athlete samples for the 2016 Rio Olympics.60
With this intended method, the natural gene for EPO is examined to see if
the intron DNA sequence, a sequence that would get cut out if the EPO
gene was genetically modified, is still intact.61 Since then, WADA has
funded a similar test to apply to other potential doping genes. 62 This new
method of detection was used to detect EPO, IGF1, and several other
genes.63 Even further, researchers hypothesize that an altered form of their
current method could work for detecting CRISPR modifications.64 While
detection of a modified gene is possible, detection methods are still in the
early stages of development and require more time and resources until
they can be used routinely.65
E. Genetic Experimentation Scandals
There has already been a human gene therapy scandal, suggesting it is
only a matter of time before there is a human gene doping scandal. In
2018, Chinese scientist He Jiankui announced that his team used CRISPR
gene editing on human embryos.66 Jiankui claimed to have disabled CCR5,

58. Athlete Biological Passport, WORLD ANTI-DOPING AGENCY, https://www.wadaama.org/en/athlete-biological-passport [https://perma.cc/8DJB-6XWL].
59. Athlete Biological Passport Operating Guidelines, WORLD ANTI-DOPING AGENCY
3, 27 (June 2019) https://www.wada-ama.org/sites/default/files/resources/files/guidelines
_abp_v71.pdf [https://perma.cc/JH3R-DZU8].
60. Everts, supra note 48 (“[S]amples collected in Rio will be tested for gene
doping at some point, even though the test was not run during the Olympics itself.”).
61. Id.
62. Eddie N. de Boer et al., A Next-Generation Sequencing Method for Gene
Doping Detection that Distinguishes Low Levels of Plasmid DNA Against a Background
of Genomic DNA, 26 GENE THERAPY 338, 338 (July 11, 2019), https://www.nature.com/
articles/s41434-019-0091-6.pdf [https://perma.cc/D9YZ-HPFX].
63. Id.
64. Id. at 345. (“For [CRISPR-Cas9] gene doping to be detected, modification of
our method will be required[;] . . . [i]n this way our method can detect induced alterations
in gene expression.”).
65. Id. (“To summarize, our method outperforms existing PCR-based methods in
many aspects and can be further developed into a routine method for detection of gene doping
of multiple genes in all sports.”).
66. David Cyranoski, What CRISPR-Baby Prison Sentences Mean for Research,
577 NATURE 154, 154 (Jan. 3, 2020), https://www.nature.com/articles/d41586-020-00001-y
[https://perma.cc/XJ8D-3RB6] [hereinafter CRISPR-Baby Prison Sentences].
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a gene which encodes a protein that allows HIV to enter cells. 67 To
complete his experiments, Jiankui forged ethics-review documents and
swapped blood samples to circumscribe laws preventing the use of HIVinfected people in experiments involving reproductive technologies.68
News of Jiankui’s experiment emerged the week of his presentation at the
Second International Summit on Human Genome Editing; he had posted
YouTube videos previously but had never presented his experiment publicly.69
Jiankui was subsequently fined three million yuan (around $450,000), banned
from ever working with human reproductive technology again, and
sentenced to three years in prison for “illegal medical practice.”70
Since Jiankui’s experiment was announced, eighteen scientists from
seven different nations have called for a global moratorium on all clinical
experimentation of human germline cells.71 The proposed moratorium is
not intended to be a permanent ban, but rather a break to allow for the
development of a proper international framework.72 This proposed moratorium
is a point of contention; some scientists fear it will drive other scientists
to continue their experimentations “underground.”73 China’s government
responded to the controversy by approving a National Research Ethics
Committee with the goal to “strengthen the coordination and implementation
of a comprehensive and consistent system of ethics governance for science
and technology.” 74 The People’s Republic of China Civil Code was
promulgated in May of 2020 and contains a “Personality Rights” section
which addresses the issues of human embryo and genome research.75
67. David Cyranoski, The CRISPR-Baby Scandal: What’s Next for Human GeneEditing, 566 NATURE 440, 440 (Mar. 11, 2019), https://www.nature.com/articles/d41586019-00673-1 [https://perma.cc/T7ZP-6W8S].
68. Id.
69. David Cyranoski, CRISPR-Baby Scientist Fails to Satisfy Critics, 564 NATURE
13, 13 (Nov. 30, 2018), https://www.nature.com/articles/d41586-018-07573-w [https://
perma.cc/C26Z-H93T] [hereinafter Scientist Fails to Satisfy Critics].
70. CRISPR-Baby Prison Sentences, supra note 66.
71. Rob Stein, Scientists Call for Global Moratorium on Creating Gene-Edited
Babies, NPR (Mar. 13, 2019, 2:01 PM), https://www.npr.org/sections/health-shots/2019/
03/13/701549223/call-for-global-moratorium-on-creating-gene-edited-babies [https://perma.
cc/F4TP-4287].
72. Id.
73. Id.
74. Shaoni Bhattacharya, China Approves Ethics Advisory Group Almost a Year
after CRISPR Scandal, BIONEWS (Aug. 12, 2019), https://www.bionews.org.uk/page_144245
[https://perma.cc/UNK2-Q9AT].
75. Yanru Chen, PRC Civil Code Series – 04: The Thing About Part IV Personality
Rights, CHINA JUST. OBSERVER (July 12, 2020), https://www.china justiceobserver.com/
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Despite the outcries for a moratorium, Russian scientist Denis Rebrikov
still plans to proceed with a human germline experiment.76 He plans to use
CRISPR technology to “fix” a genetic mutation in the GJB2 gene that
impairs hearing.77 Rebrikov has not publicly announced a timeline for his
experiment.78 Meanwhile, the Russian Health Ministry has publicly supported
the World Health Organization’s (“WHO”) moratorium stance against
making inheritable changes to the human genome.79 The difference between
Rebrikov and Jiankui in relation to the moratorium is that Rebrikov has
been transparent about his experiment and looks to pass his ethical review
instead of avoiding it like Jiankui.
III. APPLICABLE LAW
A. International Doping Authority
WADA has already banned gene doping, however, it is unclear whether
WADA should be the agency regulating a technology with stakeholders
not just in international sports, but other sectors such as health and
science. Since WADA’s inception in 1999 with The Lausanne Declaration
on Doping in Sport, it has been the forefront regulatory agency for doping
in international sports. 80 In 2005, the United Nations Educational,
Scientific and Cultural Organization (“UNESCO”) held the International
Convention Against Doping in Sport.81 Through this convention, WADA
created guidelines for the previously drafted World Anti-Doping Code

a/prc-civil-code-series-04-the-thing-about-part-iv-personality-rights [https://perma.cc/
UB2F-YNGY].
76. See Dan Robitzski, Russian Scientist Still Plotting to Create More CRISPR
Babies, NEOSCOPE (Sept. 4, 2020), https://futurism.com/neoscope/russian-scientist-plottingcreate-crispr-babies [https://perma.cc/9LPH-GHPE].
77. Jon Cohen, Embattled Russian Scientist Sharpens Plans to Create Gene-Edited
Babies, AM . ASS ’ N FOR THE ADVANCEMENT OF S CI . (Oct. 21, 2019), https://www.
sciencemag.org/news/2019/10/embattled-russian-scientist-sharpens-plans-create-geneedited-babies [https://perma.cc/5BAX-L5GS].
78. Id.
79. Olga Dobrovidova, Calling Embryo Editing ‘Premature,’ Russian Authorities
Seek to Ease Fears of a Scientist Going Rouge, STAT (Oct. 16, 2019), https://www.
statnews.com/2019/10/16/russia-health-ministry-calls-human-embryo-editing-premature/
[https://perma.cc/ZTY2-NR49].
80. Angela Schneider, The Concept of Doping, in ROUTLEDGE HANDBOOK OF DRUGS
AND SPORT 9, 10 (Verner Moller et al. eds., 2015); see WORLD ANTI-DOPING AGENCY, supra
note 4.
81. International Convention Against Doping in Sport 2005, UNITED NATIONS
EDUC., S CI. AND CULTURAL ORG. (Oct. 19, 2005), http://portal.unesco.org/en/ev.phpURL_ID=31037&URL_DO=DO_TOPIC&URL_SECTION=201.html [https://perma.cc/
6Y3K-FT3Z].
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(“The Code”).82 The Code provides the international standards for testing,
laboratories, prohibited substances, and code compliance.83 Violations of
The Code are reviewed with strict liability, with WADA as the enforcement
agency.84
The Code contains the current gene doping ban,85 but this ban is only
reflective of WADA’s opinion of gene editing technologies. Regulations
on gene doping should consider the opinions of all stakeholders involved,
such as medical professionals and human genome researchers. Gene doping
is currently regulated like any other form of doping even though its complexity
and wide-reaching effects makes it vastly different from traditional doping
methods.
B. International Genome Editing Authority
There have been attempts by international organizations to address bioethical
concerns surrounding human genome editing, but these attempts lack the
requisite collaborative effort necessary to implement comprehensive
international regulations. One of the first international bioethical human
experimentation documents, the Helsinki Declaration, originated from the
Geneva Convention in 1964.86 This declaration set the ethical international
human experiment standards and has been amended several times since
its inception; the latest amendment came from the 64th World Medical
Association General Assembly in 2013.87
In 1982, the World Health Organization (“WHO”) and the Council for
International Organization of Medical Sciences (“CIOMS”) collaborated
to release the International Ethical Guidelines for Health-related Research

82. Id.
83. The Code, WORLD ANTI-DOPING AGENCY, https://www.wada-ama.org/en/whatwe-do/the-code [https://perma.cc/YLE5-6G8Q].
84. World Anti-Doping Code, WORLD ANTI -D OPING AGENCY 13–14, 94 (Jan. 1,
2021), https://www.wada-ama.org/sites/default/files/resources/files/2021_code.pdf [https://
perma.cc/PB75-CFQM].
85. World Anti-Doping Code International Standard Prohibited List, WORLD ANTIDOPING AGENCY 13 (2021), https://www.wada-ama.org/sites/default/files/resources/files/
2021list_en.pdf [https://perma.cc/FKF8-4W7Q].
86. WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving
Human Subjects, WORLD MED. ASS’N (July 9, 2018), https://www.wma.net/policiespost/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-humansubjects/ [https://perma.cc/FS4N-ETT6].
87. Id.
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Involving Humans.88 This document explains how the principals set out
in the Helsinki Declaration should be applied in experiments involving
humans.89 Then in 1997, UNESCO released the Universal Declaration on
the Human Genome and Human Rights. 90 This declaration states, “[n]o
research or research applications concerning the human genome . . . should
prevail over respect for the human rights, fundamental freedoms and human
dignity of individuals.”91
Furthermore, WHO has taken additional steps to address potential
ethical questions regarding human genome experimentation. In 2018, the
WHO Expert Advisory Committee on Developing Global Standards for
Governance and Oversight of Human Genome Editing (“The Committee”)
was set up by the Director General of the WHO.92 The Committee is
tasked with examining the current scientific, ethical, social, and legal
challenges surrounding human genome editing, as well as developing
appropriate oversight and governance mechanisms for these experiments
at all levels.93 In 2019, the Committee approved the first phase of a global
registry to track all research on human genome editing.94 The registry
would track both somatic and germline clinical trials and ensure these
trials are proceeding in an ethical manner.95 The Committee released its
suggested governance framework in 2021. 96 This document discusses

88. International Ethical Guidelines for Health-Related Research Involving Humans,
COUNCIL FOR INT’L ORG. OF MED. SCI. ix (2016), https://cioms.ch/wp-content/uploads/
2017/01/WEB-CIOMS-EthicalGuidelines.pdf [https://perma.cc/ERH3-88KA].
89. Id. at 57.
90. Universal Declaration on the Human Genome and Human Rights, UNITED NATIONS
EDUC., SCI. AND CULTURAL ORG. (Nov. 11, 1997), http://portal.unesco.org/en/ev.phpURL_ID=13177&URL_DO=DO_TOPIC&URL_SECTION=201.html [https://perma.cc/
AEJ5-Z8PQ].
91. Id. art. 10.
92. Call for Contribution: Advisory Committee on Developing Global Standards
for Governance and Oversight of Human Genome Editing – Now Closed, WORLD HEALTH
ORGANIZATION [WHO] (July 10, 2020), https://www.who.int/news-room/articles-detail/
call-for-contribution-advisory-committee-on-developing-global-standards-for-governanceand-oversight-of-human-genome-editing [https://perma.cc/N44W-DVDL] [hereinafter Call
for Contribution].
93. Id.
94. WHO Launches Global Registry on Human Genome Editing, WORLD HEALTH
ORGANIZATION [WHO] (Aug. 29, 2019), https://www.who.int/news-room/detail/2908-2019-who-launches-global-registry-on-human-genome-editing [https://perma.cc/L33CGY6W].
95. Id.
96. WHO Issues New Recommendations on Human Genome Editing for the
Advancement of Public Health, WORLD HEALTH ORGANIZATION [WHO] (July 12, 2021),
https://www.who.int/news/item/12-07-2021-who-issues-new-recommendations-on-humangenome-editing-for-the-advancement-of-public-health [https://perma.cc/S3EA-QR47].
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various factors of good governance of human genome editing97 and is an
important step towards international governance of human genome editing.
This document could be the basis for developing an international solution
for this issue.
C. National Genome Editing Authorities
National bodies have been developing regulations for human genome
therapy at different rates, which could lead to potential conflicts in the
future. In May 2020, the Civil Code of the People’s Republic of China
was adopted and contains a section that was a direct response to the He
Jiankui scandal.98 This provision states: “A medical and scientific research
activity related to human genes, embryos, or the like shall be done in
accordance with the relevant provisions of laws, administrative regulations,
and the regulations of the State, and may not endanger human health, offend
ethics and morals, or harm public interests.” 99 This provision imposes
civil liability on those who violate ethics and morals in human germline
experiments on top of any possible criminal liability they may face.100
In contrast, the United States has taken a different approach. The US
regulates human genome editing through its federal funding of the Food
and Drug Administration (“FDA”). A “rider” provision of the 2016
spending bill bars the FDA from considering any clinical trial application
“in which a human embryo is intentionally created or modified to include
a heritable genetic modification.”101 This provision was added to every

97. WHO Expert Advisory Commission on Developing Glob. Standards for
Governance and Oversight of Human Genome Editing, Human Genome Editing: A Framework
for Governance, WORLD HEALTH ORGANIZATION [WHO] (July 12, 2021), https://www.
who.int/publications/i/item/9789240030060 [https://perma.cc/Z2FQ-5UEM] [hereinafter
A Framework for Governance].
98. Lingqiao Song & Yahn Joly, After He Jianku: China’s Biotechnology Regulation
Reforms, 21, MED. L. INT’L. 174, 178 (Feb. 16, 2021), https://journals.sagepub.com/doi/
10.1177/0968533221993504 [https://perma.cc/29PT-6CZJ]; see Zhonghua Renmin
Gongheguo Minfa Dian (中华人民共和国民法典) [Civil Code of the People’s Republic
of China] (promulgated by the Nat’l People’s Cong., May 28, 2020, effective Jan. 1, 2021),
art. 1009, P.R.C. LAWS.
99. Id. at art. 1009.
100. See generally id.
101. Jocelyn Kaiser, Update: House Spending Panel Restores U.S. Ban on GeneEdited Babies, AM . ASS ’ N FOR THE ADVANCEMENT OF S CI. (June 4, 2019, 1:45 PM),
https://www.sciencemag.org/news/2019/06/update-house-spending-panel-restores-us-bangene-edited-babies [https://perma.cc/6LJA-JANL].

171

COSTA.DOCX (DO NOT DELETE)

1/24/2022 1:50 PM

subsequent spending bill, but was not included in the 2020 draft.102 The
National Institute of Health also refused to fund any gene therapy research
that involves human embryos.103 These regulations make public funding
of human germline cell editing in the US practically impossible. Human
somatic cell therapy is possible in the US, as the FDA approved the first
treatment of this kind in 2020.104 Scott Gottlieb, former FDA commissioner,
predicted that by 2025 the FDA would be approving between ten and
twenty gene therapies per year.105 Additionally, the United States followed
WADA’s lead and banned gene doping outright.106
The United Kingdom was one of the first countries to set a regulatory
framework in place for human genome editing. The Human Fertilization
and Embryology Act of 1990 (“HFE”) prohibits embryos that have had
germline DNA altered from being placed inside a woman. 107 The HFE
does allow other forms of human genome research on the basis of licenses
issued by the Human Fertilization and Embryology Authority.108 The HFE
was the first national policy regulating the use of human embryos in the
world and has been continuously amended by Parliament to reflect
changing public opinion. 109 The HFE has some of the most extensive
requirements of current national legislation: it has a license committee, it
calls for random inspections of human genome research, and it sets strict

102. Id.
103. Francis S. Collins, Statement on NIH funding of Research Using Gene-Editing
Technologies in Human Embryos, N AT ’ L INST . OF HEALTH (Apr. 28, 2015), https://
www.nih.gov/about-nih/who-we-are/nih-director/statements/statement-nih-fundingresearch-using-gene-editing-technologies-human-embryos [https://perma.cc/53D5-U9DF].
104. FDA Approves First Cell-Based Gene Therapy for Adult Patients with Relapsed
or Refractory MCL, FDA (July 24, 2020), https://www.fda.gov/news-events/pressannouncements/fda-approves-first-cell-based-gene-therapy-adult-patients-relapsed-orrefractory-mcl [https://perma.cc/6JNZ-WJXV].
105. Arlene Weintraub, Pharma’s Gene and Cell Therapy Ambitions Will Kick into
High Gear in 2020-Despite Some Major Hurdles, F IERCE P HARMA (Dec. 19, 2019),
https://www.fiercepharma.com/pharma/gene-and-cell-therapy-r-d-will-kick-into-high-gear2020-despite-hurdles-experts-say [https://perma.cc/U3ET-HQQL].
106. Office of National Drug Control Policy Reauthorization Act of 2006, H.R.6344,
109th Cong. § 701 (2006).
107. Francesca Lake, UK Parliamentary Office Publishes Brief on Human Germline
Genome Editing, BIOTECHNIQUES (Jan. 22, 2020), https://www.biotechniques.com/crispr/
uk-parliamentary-office-publishes-brief-on-human-germline-genome-editing/ [https://
perma.cc/D2ES-VQM6].
108. Britta van Beers, Rewriting the Human Genome, Rewriting Human Rights Law?
Human Rights, Human Dignity, and Human Germline Modification in the CRISPR Era, 7
OXFORD J.L. & BIOSCIENCES 1, 19 (June 9, 2020), https://academic.oup.com/jlb/advancearticle/doi/10.1093/jlb/lsaa006/5841599 [https://perma.cc/9W4W-9TP5].
109. Jonathan LaTourelle, Human Fertilisation and Embryology Act (1990), EMBRYO
PROJECT ENCYCLOPEDIA (Dec. 19, 2014), https://embryo.asu.edu/pages/human-fertilisationand-embryology-act-1990 [https://perma.cc/JF77-EGAM].
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standards for research centers to maintain their status as licensed for
human genome research.110
IV. LEGAL ANALYSIS
The world will only benefit from gene editing technology if there are
internationally agreed upon standards in all areas of human genome
editing including detailed regulations on human germline edits, human
somatic edits, and gene doping. As it currently stands, nations are developing
regulations at different rates which could lead to international conflict if
one nation allows human genome research that other nations consider
unethical or unsafe. International standards are necessary for the enforcement
of gene doping regulations, as uniform international guidelines can prevent
the issue of different nations defining “therapeutic” use of genome editing
at different levels. The current regulation of gene doping could potentially
prevent further progression of gene therapy in the future; thus, it is important
to develop a detailed and adaptive regulatory framework. Ultimately, the
goal of international regulations should be to allow for the safe development
and application of gene technology so there can be a time in the future
where there is no negative stigma surrounding the use of safe gene therapy.
A. Gene Doping Has a High Potential for Abuse
Gene doping may appear to some athletes as a more attractive alternative
to traditional doping because of its potentially undetectable application.111
International athletes face high pressure to succeed, so the allure of gaining
an undetectable competitive advantage could eventually persuade an athlete
to attempt gene doping. WADA has taken steps to address this issue, but
they will need a more comprehensive detection-based model to enforce
gene doping regulations. As it currently stands, WADA’s current ban on
gene doping is an empty threat without proper detection methods.
Many international athletes face pressure from their respective countries to
win at all costs. The difference between first and second place may be a
change of millions of dollars and national fame; athletes sometimes choose

110. How We Regulate, HUM. FERTILISATION & EMBRYOLOGY AUTH., https://www.
hfea.gov.uk/about-us/how-we-regulate/ [https://perma.cc/XC8Z-285W].
111. Wenner, supra note 38.
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shortcuts to achieve money and glory.112 Lance Armstrong, a highly
successful international cyclist who was caught blood doping, admits that
he would “probably do it again” when asked if he would change anything.113
There even appears to be a “cheater’s high” which boosts self-satisfaction
when cheaters are able to get away with their scheme.114 For these reasons,
abuse of technology to improve athletic performance should be expected
and the proper regulatory and enforcement methods must be set to dissuade
the dangerous application of gene technology to doping. As Dr. Friedman,
chair of WADA genetic panel has stated: “If you ask me how many years
it’ll be before [gene doping happens], well, I’d say a very long time. But
how many more years before some idiot does something stupid? That
could be tomorrow.”115
As previously mentioned, WADA considered the idea of genome
sequencing Olympians to provide a type of “gene passport.”116 They dropped
this idea due to the expense of genome sequencing every athlete, an issue
no longer as influential today. 117 Adding a “gene passport” to WADA’s
preexisting Athlete Biological Passport system is a viable detection-based
model that should be implemented. Individual nations have alread y
decided that this is a worthwhile task, as China announced that its athletes
for the 2022 Olympics will be genome sequenced.118 China’s actions are
not an attempt to detect gene doping, rather they are attempting to identify
laboratory standards for base genetic markers to help with their selection
of future Olympic athletes. 119 Although this is a different usage of the
“gene passport” proposed, the usage still lends itself to supporting the
validity of the “gene passport.”
112. The Psychology of Cheating in Sports, AURORA UNIVERSITY (Aug. 16, 2019),
https://online.aurora.edu/psychology-of-cheating-in-sports/#:~:text=However%2C%20
the%20fundamental%20reason%20why,Athletes%20want%20to%20win.&text=As%20
a%20result%2C%20some%20athletes,that%20being%20the%20best%20brings [https://
perma.cc/6UCB-UWF5].
113. Interview by Dan Roan with Lance Armstrong, Armstrong on Drugs, History
and The Future, BBC: SPORT (Jan. 26, 2015), https://www.bbc.com/sport/av/cycling/309
84312 [https://perma.cc/3J4L-F6FV].
114. Nicole E. Ruedy et al., The Cheater’s High: The Unexpected Affective Benefits
of Unethical Behavior, 105 J. PERSONALITY & SOC. PSYCH. 531, 532 (2013).
115. Maureen Salamon, Could Gene Doping Be Part of Future Olympics?,
MEDICINENET (July 26, 2012), https://www.medicinenet.com/script/main/art.asp?article
key=160697 [https://perma.cc/T3ND-DTRV].
116. Niiler, supra note 56.
117. Id.
118. Stephen Chen, Gattacca by 2022? China to Select Winter Olympics Athletes by
Their Genes, SOUTH CHINA MORNING POST (Aug. 31, 2018), https://www.scmp.com/news/china/
science/article/2161866/china-genetically-screen-its-athletes-ensure-best-compete-2022
[https://perma.cc/96T9-RTAZ].
119. Id.
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Genome sequencing appears to be a viable solution for detecting gene
doping, but it might raise issues relating to genetic information, privacy,
and discrimination. 120 If WADA attempts to set genetic markers as
laboratory standards for “acceptable” athletic performance, it might go
against the UNESCO Universal Declaration on the Human Genome and
Human Rights.121 This declaration states: “No one shall be subjected to
discrimination based on genetic characteristics that is intended to infringe
or has the effect of infringing human rights, fundamental freedoms and
human dignity.”122
WADA must be careful if it wishes to implement genome screening as
an additional requirement to their ABP program. WADA currently uses
ABP to monitor athletes’ blood and urine for biological variables over
time that suggest doping, not to determine threshold biological markers.123
This difference is important, as attempting to set threshold biological markers
could lead to genetic discrimination in the case of genome sequencing.
If WADA set biological markers to detect gene doping, athletes who
did not perform gene doping but have natural mutations could become
excluded from international sports. There are noted examples of athletes
who have natural mutations that improve athletic ability, such as Eero
Mäntyranta, the 1964 Olympic gold medalist for skiing who was reported
to have unusually high amounts of red blood cells.124 If genome sequencing
is an added requirement of WADA’s ABP program, WADA must compare
the athlete’s samples against the athlete’s past samples to determine if
there are any unnatural changes instead of attempting to set threshold
biological markers. This approach could work if athletes accept the idea,
which current reports show that some are receptive to the idea if it is
necessary to keep the sport clean.125
B. Decreased Public Opinion on Genome Editing Can Halt its Progress
International standards for applying genome editing technology can decrease
the potential for future scandals. An internationally agreed upon standard
120. G.A. Res. 53/152, at art. 6, Universal Declaration on the Human Genome and
Human Rights (Nov. 11, 1997).
121. Id.
122. Id.
123. Athlete Biological Passport, WORLD ANTI-DOPING AGENCY, https://www.wadaama.org/en/athlete-biological-passport [https://perma.cc/4HHU-33AM].
124. Filipp, supra note 42, at 434.
125. See, e.g., Niiler, supra note 56.
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could prevent abuse of this technology as nations develop their own human
genome editing regulations, likely at varying levels of strictness. Scandals
easily sway public opinion, and negative public opinion could halt the
growth of gene therapy.
The Russian doping example shows how scandal can impact perception,
especially when a responding regulatory body is unprepared for the situation.
Due to the unprecedented nature of the Russian scandal, the IOC and
WADA had no rules or procedures on how to handle such a situation.126
Their unpreparedness was visible in their disjointed response. WADA’s
preliminary recommendation was for a “blanket-ban” on all Russian athletes
for the 2016 Rio Olympics127 which IOC rejected, rather deciding to let
the individual IFs determine athlete eligibility.128 The IOC did ultimately
agree to a four year “blanket-ban” on Russia nearly five years after the
controversy was discovered.129 Their handling of the situation received a
negative public reaction, with some viewing IOC’s credibility as badly
damaged.130
Genome editing and its lucrative potential will attract many researchers.
As was the case with He Jiankui, some scientists willingly push ethical
boundaries to complete experiments in this field.131 Denis Rebrikov is
another known scientist interested in human genome experiments,132 but
unlike him there may be others who are not as willing to pass ethical standards.
If most of the public exposure to genome editing consists of scandals and
foregone ethical practices, then harsh restrictions will likely limit the
potential of genome technology.
He Jiankui is facing three years of jail time for “illegal medical practice,”133
but would likely have faced more severe charges had his experiment taken
place elsewhere. In the UK, the HFE bars human birth of genetically edited

126. Alex Brokaw, How does the International Olympic Committee Solve a Problem
like Russian Doping?, THE VERGE (July 19, 2016, 2:17 PM), https://www.theverge.com/
2016/7/19/12222086/international-olympics-committee-delays-decision-to-ban-russia
[https://perma.cc/FX6J-BCJM].
127. Macguire, supra note 16.
128. Id.
129. WADA Executive Committee Unanimously Endorses Four-Year Period of NonCompliance for the Russian Anti-Doping Agency, WORLD ANTI-DOPING AGENCY (Dec. 9,
2019), https://www.wada-ama.org/en/media/news/2019-12/wada-executive-committeeunanimously-endorses-four-year-period-of-non-compliance [https://perma.cc/N29C-XMQ8].
130. See, e.g., Liam Morgan, Exclusive: Radcliffe Claims Credibility of IOC Badly
Damaged by Response to Russian Doping Scandal, INSIDE THE GAMES (Oct. 25, 2017),
https://www.insidethegames.biz/articles/1057040/exclusive-radcliffe-claims-credibilityof-ioc-badly-damaged-by-response-to-russian-doping-scandal [https://perma.cc/6QY5-Q3LU].
131. Scientist Fails to Satisfy Critics, supra note 69.
132. Cohen, supra note 77.
133. CRISPR-Baby Prison Sentences, supra note 66.
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embryos134 so Jiankui would likely have faced a minimum sentence of ten
years for the violation of this law. 135 In the US, Jiankui would face
penalties for failing to obtain FDA approval for his research, constituting
a violation of the Federal Food, Drug and Cosmetics Act and carrying
criminal penalties and imprisonment of up to ten years.136 Although most
people agree that the punishment for Jiankui is proportional to his actions,137
moral and ethical lines may become blurred in a not so clear-cut case. If
there is no internationally agreed upon standards, then each national
legislature would develop their own set of human genome regulations at
their own pace, which could lead to conflict regarding future scandals and
unethical practices. Agreed upon international standards can act as the
bare minimum requirement that national legislative bodies can build upon
to fit their constituents’ ethical views on genome technology.
C. What is Proper Punishment for WADA’s Current Gene Doping Ban?
To avoid a situation like the disjointed response to the Russian doping
scandal, WADA and IOC must be prepared to enforce their regulations. It
is too soon to tell how WADA and IOC would react if they discovered an
Olympian gene doping, but a more extensively thought-out regulatory
framework could solve this problem before it occurs.
If WADA and IOC uphold a ban on gene doping, they must also prepare
for the possibility of state-sponsored gene doping. Both organizations
were unprepared for the Russian scandal, but hopefully this experience
has readied them for future enforcement actions. WADA has begun funding
methods of detecting gene doping,138 however, these tests are still in their
preliminary stages and need the necessary lab infrastructure to implement.139
134.
135.

Lake, supra note 107.
Lie Lijie (刘立杰), Three Legal Issues With Gene-Edited Babies (基因编辑婴儿
的三大法律问题), JRCB (Jan. 14, 2019), http://www.jcrb.com/FYFZ/zxbd/201901/
t20190114_1952628.html [https://perma.cc/3US8-YBWC].
136. Josephine Johnston, He Jiankui is Going to Jail. Would the U.S. Criminally
Prosecute a Rogue Gene-Editing Researcher?, STAT (Dec. 31, 2019), https://www.
statnews.com/2019/12/31/he-jiankui-jail-prosecute-rogue-gene-editing-researcher/ [https://
perma.cc/T2YK-X6RJ].
137. Expert Reaction to News That He Jiankui Has Been Sentenced to Three Years
in Prison, SCI. MEDIA CTR. (Dec. 30, 2019), https://www.sciencemediacentre.org/profrobin-lovell-badge-response-to-news-that-he-jiankui-has-been-sentenced-to-three-yearsin-prison/ [https://perma.cc/H83N-ABAX].
138. EPO Detection, supra note 44.
139. De Boer, supra note 62, at 339, 345.
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If traditional doping labs could be manipulated as they were during the
Russian doping scandal,140 then it is likely that the more complex gene
detection results could also be manipulated.
IOC and WADA had a difficult time agreeing on a proper punishment
for the Russian scandal and determining a proper punishment for gene
doping will only become a more problematic task. If the punishment is
too severe, then the advancement of gene therapy technology could suffer.141
Scientists and athletes alike could be dissuaded from pursing gene therapies
that could greatly improve an athlete’s quality of life but also improve
athletic performance if they are worried of possible punishment. Some
theoretical examples of possible gene therapy applications that fall in this
grey area are procedures that could potentially improve an athlete’s
recovery from major injuries or procedures that could potentially increase
an athlete’s longevity. 142 If the punishment is not severe enough, then
critics will call out IOC and WADA for failing to uphold principals of
fairness. It is a no-win situation.
Current gene doping regulations are only reflective of international
sports agencies’ opinion of gene therapy when this potential abuse affects
many different stakeholders. Cooperation between national governments
and international organizations is needed to effectively manage all constituent
parties in this matter. Theodore Friedmann, head of WADA’s gene doping
advisory panel stated that implementing gene doping in athletes is “very
hard, [i]f you think about how hard it is to design and work through the
technical and procedural issues for human gene therapy . . . . You can’t
just go throwing around things in experimental procedures with humans.
There are international constraints.”143 Accordingly, WADA would benefit
in collaborating with other international organizations and national bodies
to develop an effective response to gene doping.
The current gene doping ban puts WADA in a difficult situation. An
international framework developed by multiple stakeholders in this issue
can guide responses to potential gene therapy abuses. WADA’s outright
ban of gene doping was a preemptive response to this technological
advancement; it is only right that international regulations continue
to adapt and expand with the growth of gene editing. These regulations
140. Grigory Rodchenkov, director of Russia’s anti-doping laboratory, was accused
of being “at the heart” of the doping Russian scandal. Russian Doping: Who is Whistleblower
Grigory Rodchenkov?, BBC (July 19, 2016), https://www.bbc.com/news/world-europe36833962 [https://perma.cc/6533-FJV9].
141. R. Alta Charo, The Legal and Regulatory Context for Human Gene Editing, 32
ISSUES IN SCI. & TECH. 3 (2016), https://issues.org/the-legal-and-regulatory-context-forhuman-gene-editing/ [https://perma.cc/4U4L-87A7].
142. See Huard, infra note 161.
143. Niiler, supra note 56.

178

COSTA.DOCX (DO NOT DELETE)

[VOL. 23: 157, 2021]

1/24/2022 1:50 PM

Current State of Gene Doping
SAN DIEGO INT’L L.J.

must not be so strict as to limit the development of gene therapy, but they
must draw the ethical boundaries of acceptable practice so to continue the
maturation of gene technologies.
D. WADA Should Not be Treating Gene Doping as if it Were
Any Other Typical Form of Doping
The current gene doping ban lacks specificity and treats gene doping like
any other doping violation prohibited by the World Anti-doping Code.
Conflict can arise between what WADA considers as gene doping compared
to what other national bodies consider as gene doping. More specifically,
“therapeutic” uses of gene editing can be defined differently by different
nations absent any international agreed upon standard. This ban also
dissuades scientists from researching how gene doping could be applied
for athletics, which will prevent the advancement of sports medicine.
Currently, if any issues arise between WADA or IOC and athletes, the
conflict is resolved through arbitration or mediation with the Court of
Arbitration for Sport (“CAS”).144 CAS is based in Switzerland and hears
sports-related arbitration cases and appeals.145 The parties decide which
law should govern their dispute, and absent any designation, Swiss law is
applied.146 In either case, the World Anti-doping Code would be influential
in determining a resolution for the dispute. The World Anti-Doping Code
bars “the non-therapeutic use of genes, genetic elements and/or cells that
have the capacity to enhance athletic performance.”147 This creates the
potential issue of various national legislatures defining “therapeutic” genome
edits at different capacities. A centralized international authority would
help prevent an issue such as this.
Currently, different national bodies have different organizations that
determine the definition of therapeutic use of gene editing. The US has
the FDA which approves clinical applications of gene editing through its
144. Court of Arbitration for Sport, WORLD ANTI-DOPING AGENCY, https://www.
wada-ama.org/en/court-of-arbitration-for-sport [https://perma.cc/ZUC7-CUMW].
145. Matthew Buckle, Court of Arbitration for Sport (CAS), NORTON ROSE
FULBRIGHT (June 2018), https://www.nortonrosefulbright.com/en-us/knowledge/publications/
048b7aeb/court-of-arbitration-for-sport-cas [https://perma.cc/N9TG-CX4M].
146. Court of Arbitration for Sport, Procedural Rules, Special Provisions Applicable
to the Ordinary Arbitration Procedure, R45: Law Applicable to the Merits, CODE
OF SPORTS-RELATED ARBITRATION 1, 21 (Jan. 1, 2019), https://www.tas-cas.org/fileadmin/
user_upload/Code_2019__en_.pdf [https://perma.cc/TS5N-J2Z8].
147. 2004 Prohibited List, supra note 37.
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new drug application and biologics license application.148 The UK has the
Embryology Authority and the regulations set in the HFE.149 China has its
newly updated civil code. 150 All these potential authorities might find
some human genome experiments as having more therapeutic value compared
to other authorities. A clear international standard defining the limits of
therapeutic human genome editing will help prevent future conflicts that
can arise with different legislative bodies defining a term.
Furthermore, WADA must prepare for a situation where an athlete
unintentionally gains an athletic advantage through therapeutic gene editing.
What happens if an athlete who suffers from muscular dystrophy uses
gene therapy and as a result of the treatment gains a competitive advantage?151
This issue is similar to what happened when Oscar Pistorius wanted to
compete in the 2008 Olympics as a double amputee.152 An initial study
done by the International Association of Athletics Federations concluded
that Pistorius’ carbon fiber blades that replaced his legs gave him an unfair
advantage.153 He was thus banned from competing in the 2008 Olympics.154
Although Pistorius was able to reverse his Olympic ban with an appeal to
CAS in time to compete for the 2012 games, 155 his initial ban from the
games due to his alleged competitive advantage hints at what might
happen in the muscular dystrophy hypothetical. Pistorius was able to
appeal his ban because subsequent studies showed that many amputee and
intact-limb subjects had similar physiological performance for sprinting
events, the events in which he participated.156 Though the gene editing for
148. What is Gene Therapy?, U.S. FOOD AND DRUG ADMIN. (July 25, 2018), https://
www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-gene-therapy
[https://perma.cc/ESE5-AZ8T].
149. LaTourelle, supra note 109, at 1.
150. See Zhonghua Renmin Gongheguo Minfa Dian (中华人民共和国民法典) [Civil
Code of the People’s Republic of China] (promulgated by the Nat’l People’s Cong., May
28, 2020, effective Jan. 1, 2021) P.R.C. Laws.
151. Guilherme Artioli et al., terapia gênica, doping genético e esporte: fundamentação
e implicações para o futuro [Gene Therapy, Genetic Doping and Sport: Fundaments and
Implications for the Future], 13(5) REVISTA BRASILEIRA DE MEDICINA DO ESPORTE 349,
351 (2007) (Braz.), https://www.scielo.br/j/rbme/a/RCv3Jk3Rm4xZL9QdNfWNVKc/?lang
=pt&format=pdf.
152. Joshua Robinson, Study Suggests That Amputee Holds an Unfair Advantage,
N.Y. TIMES (Jan. 10, 2008), https://www.nytimes.com/2008/01/10/sports/othersports/10
track.html [https://perma.cc/D5WU-P2TE].
153. Id.
154. Pistorius v International Association of Athletics Federations, Decision, CAS
2008/A/1480, 13 (Ct. of Arb. for Sport Appeals 2008), http://classic.austlii.edu.au/au/journals/
ANZSportsLawJl/2008/7.pdf.
155. Id.
156. Peter Weyand, et. al., The Fastest Runner on Artificial Legs: Different Limbs,
Similar Function?, 107 J. APPLIED PHYSIOLOGY 903, 909 (2009), https://journals.physiology.
org/doi/full/10.1152/japplphysiol.00174.2009 [https://perma.cc/ZZ7T-6C4X].
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medical reasons such as muscular dystrophy might be for “therapeutic”
reasons, the athlete may still be able to gain a competitive advantage and
thus be at odds with WADA and IOC.
WADA has approached the issue of gene doping as if it were typical
doping,157 which is not the correct way to regulate this new technology.
An outright ban might provide a temporary solution to this issue, but it could
also halt the potential growth of this new technology. Future applications
of gene therapy might not fall clearly in-between the “therapeutic vs nontherapeutic use” distinction as required by WADA.158 Gene therapy could
be used not only to improve athletic performance, but possibly also to
improve athlete recovery times, extend athlete’s playing careers, and
vastly advance sports medicine.159 More research into how gene therapy
can be used to improve international sports as a whole is currently dissuaded
as the application of the technology in this way would be viewed as gene
doping. It is unfair for one stakeholder to restrict the growth of gene
therapy out of fear for the possibility of abuse. Action is necessary to ensure
that gene therapy abuses are regulated, but with regulations that are
reflective of all stakeholders involved and regulations that do not dissuade
potential research and application of this powerful technology.
E. Somatic Cell Edits or Gene Doping?
WADA’s broad gene doping ban was the correct decision at the time
the ban was enacted because of its dangerous and ethically questionable
nature, but it is imperative that WADA holds an open mind towards somatic
cell edits. If this technology becomes safe and admissible as ordinary
medical practice, then it would be wise for WADA to hold a more nuanced
approach towards their gene doping regulation.
CRISPR is one of the more widely used gene editing techniques, but
there are still risks involved with this infant technology. Studies have shown
that cells altered by CRISPR may be missing key anti-cancer mechanisms.160
CRISPR may also introduce many “off-target” genetic errors—unexpected
157. 2004 Prohibited List, supra note 37.
158. 2004 Prohibited List, supra note 37.
159. Johnny Huard et al., Gene Therapy and Tissue Engineering for Sports Medicine, 5
J. GENE MED. 93, 96–103 (2003), https://onlinelibrary.wiley.com/doi/10.1002/jgm.344
[https://perma.cc/RN2G-2FJ5].
160. Daniel Oberhaus, DNA Damage from CRISPR Has Been ‘Seriously Underestimated’,
VICE (July 17, 2018), https://www.vice.com/amp/en/article/a3qv7a/dna-damage-fromcrispr-has-been-seriously-underestimated [https://perma.cc/5HKD-F6HZ].
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deletions and scrambling of genetic code.161 The CRISPR method has
improved greatly since its discovery,162 which suggests that more research
into this technology will make it safer. Prime editing, a gene therapy technique
that is more precise than CRISPR, 163 is proof that human capacity to edit
genomes will only improve with further research.
If future research proves that human gene editing can be performed
safely, then the argument to maintain a gene doping ban becomes weaker.
If gene therapy becomes a common and practical medical procedure in
twenty-five years, then certain genome edits will be more comparable to
LASIK eye surgery (“LASIK”) than to doping. IOC and WADA do not
classify LASIK as doping or as a competitive advantage.164 There will
always be inherent risks for LASIK,165 just as with gene therapy. Many
Olympic athletes undergo LASIK to correct their vision; the US speed
skating team has an official LASIK provider.166 Improved eyesight increases
athletic performance in many different Olympic sports.167 While improved
eyesight may not have the same effect on athletic performance compared
to an increased muscle growth factor or improved oxygen delivery,168 it
still can improve athletic performance. Therapeutic aspects of somatic cell
edits could result in athletes maintaining healthier muscles longer,169 thus
improving all international sports.
V. P ROPOSED S OLUTION
A solution for the issue of gene doping is to expand the current
regulations on gene therapy technologies. This can be achieved through

161.
162.

Id.
Heidi Ledford, Super-Precise CRISPR Tool Enhanced by Enzyme Engineering,
NATURE (Feb. 10, 2020), https://www.nature.com/articles/d41586-020-00340-w [https://perma.cc/
7GJL-CBU9].
163. Scientists Create, supra note 33.
164. Olympians and LASIK, NORTHWEST EYE CENTER, P.C. (July 16, 2018), https://
northwest-eye.com/olympians-and-lasik/ [https://perma.cc/WVD8-2PMV].
165. LASIK Eye Surgery, MAYO CLINIC (Nov. 8, 2019), https://www.mayoclinic.
org/tests-procedures/lasik-eye-surgery/about/pac-20384774 [https://perma.cc/Y4AM-LDKZ].
166. David Evans, The Summer Olympics are Here! . . .So Let’s Talk Winter Olympics,
BETTER VISION GUIDE (Aug. 14, 2018), https://www.bettervisionguide.com/speed-skaterspamel/ [https://perma.cc/J3BW-QYL6].
167. Sally Thompson, Sports and LASIK: Which Athletes Benefit Most?, LASIKP LUS,
https://www.lasikplus.com/lasik-resources/procedure/athletes-that-benefit/ [https://perma.cc/
URL8-KQFS].
168. See Everts, supra note 48; see Franks, supra note 43.
169. Michael Le Page, Gene Doping in Sport Could Make the Olympics Fairer and
Safer, NEWSCIENTIST (Aug. 5, 2016), https://www.newscientist.com/article/2100181gene-doping-in-sport-could-make-the-olympics-fairer-and-safer/ [https://perma.cc/TF8CEXU8].
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an international treaty where all stakeholders involved are able to agree
upon acceptable human genome technology standards. The treaty should
also create a new international organization that helps enforce the regulations
set out in the treaty. In addition, WADA should look to implement genome
sequencing to their Athlete Biological Passport by 2028 to begin a gene
doping detection framework. The current gene doping ban is necessary
today, but regulatory organizations must be willing to modify their regulations
based on advancement in technology and changing societal expectations.
A. An International Treaty Can Set International Bioethical
Standards for Human Genome Technologies
The first step towards addressing the issues surrounding gene doping
would be for every nation to agree on bioethical human technology standards,
covering areas including but not limited to: human germline cell edits,
human somatic cell edits, and gene doping. While international organizations
like UNESCO and WHO have released declarations of international bioethical
standards, there have been no binding international treaties focused on the
standards of gene therapy. UNESCO, WHO, CIOMS, WADA and other
parties that have a stake in regulating human genome experimentation
should be part of the conversation to determine the best course of action.
Since the Jiankui scandal, there have been many efforts towards increased
human genome regulations. China updated its civil code to address human
genome technologies,170 and organizations such as the National Institute
of Health have supported a global moratorium on the clinical application
of human germline cells.171 The next logical progression is the implementation
of international regulations to stop any future scandals. A representative
at the next United Nations (“UN”) General Assembly should propose an
international convention on human genome technology and experimentation
standards. A treaty could build upon the bioethical principles set out in the
Helsinki Declaration,172 the International Ethical Guidelines for Health170. See Zhonghua Renmin Gongheguo Minfa Dian (中华人民共和国民法典)
[Civil Code of the People’s Republic of China] (promulgated by the Nat’l People’s Cong.,
May 28, 2020, effective Jan. 1, 2021), art. 1009, P.R.C. LAWS.
171. Francis Collins, NIH Supports International Moratorium on Clinical Application of
Germline Editing, NAT’L INSTS. OF HEALTH (Mar. 13, 2019), https://www.nih.gov/aboutnih/who-we-are/nih-director/statements/nih-supports-international-moratorium-clinicalapplication-germline-editing [https://perma.cc/4XS3-WWDV].
172. WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving
Human Subjects, WORLD MED. ASS’N. (July 9, 2018), https://www.wma.net/policies-post/
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related Research Involving Humans,173 and the Universal Declaration on the
Human Genome and Human Rights.174
Ultimately, the governance framework175 developed by the WHO Expert
Advisory Committee on Developing Global Standards for Governance
and Oversight of Human Genome Editing will be a useful document for
developing an international human genome therapy treaty. The WHO is
attempting to address the issue, but its authority would only be strengthened
with the endorsement of the UN Member States. The governance framework
emphasizes several core values:
(i) openness, transparency, honesty and accountability; (ii) responsible regulatory
stewardship; (iii) responsible stewardship of science and (iv) responsible
stewardship of research resources. The values and principles to inform what
decisions are made are (i) inclusiveness; (ii) caution; (iii) fairness; (iv) social
justice; (v) non-discrimination; (vi) equal moral worth; (vii) respect for persons;
(viii) solidarity and (ix) global health justice.176

These core values should be reflected in any international human genome
regulation. This document also suggests that international regulations would
have to come from a convention or treaty.177
Additionally, the governance framework addresses several different
scenarios in which gene therapy technology could be applied. The framework
explains a scenario and applies its core values to developing several important
questions that need to be considered when forming governance measures.178
After developing these questions, the document proceeds to list several
plausible governance mechanisms. One of the several scenarios the document
discusses is the use of gene therapy to enhance athletic ability. 179 The
document’s suggested solutions are:
a) To establish legislation, regulation, and associated guidance
distinguishing between treating a disease versus enhancing
what is considered “normal”, where international harmonization

wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-humansubjects/ [https://perma.cc/55N8-XPSE].
173. International Ethical Guidelines for Health-related Research Involving Humans,
COUNCIL FOR INT’L ORG. OF MED. SCIS. (4th ed. 2016), https://cioms.ch/wp-content/
uploads/2017/01/WEB-CIOMS-EthicalGuidelines.pdf [https://perma.cc/G2EK-SN57].
174. Universal Declaration on the Human Genome and Human Rights, UNESCO
Gen. Conf. 29 C.Res.16 (Nov. 11, 1997), endorsed by the UN General Assembly, G.A.
Res. 53/152 (Dec. 9, 1998), http://portal.unesco.org/en/ev.php-URL_ID=13177&URL_
DO=DO_TOPIC&URL_SECTION=201.html [https://perma.cc/6DMT-HG3X].
175. A Framework for Governance, supra note 97.
176. A Framework for Governance, supra note 97, at 10–11.
177. A Framework for Governance, supra note 97, at 28.
178. A Framework for Governance, supra note 97, at 40.
179. A Framework for Governance, supra note 97, at 47–49.
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b)
c)
d)
e)
f)
g)

of these legislative and regulatory frameworks are the most
desirable;
Allowing individual ministries to make policies governing
this use of human genome editing;
The use of research funds solely for the health purposes and
not for the purpose of enhancing athletic ability;
A moratorium on the use of genome technology in this capacity
through use of bans by global governing bodies for professional
and elite sports;
Professional self-regulation through the use of ethical guidelines;
Public advocacy and activism on the issue to determine the
position of the many interest groups involved; and
Development of research ethics guidelines and research ethics
review by review committees.180

The framework goes on to list several other scenarios and possible
solutions to them.181 The framework lists out several suggested solutions
to issues, but an ultimate satisfying solution can only be developed through
collaboration of multiple international and national regulatory bodies. Many
of the solutions recommended by the framework suggest that international
harmonization of procedures and regulations is desirable, thus a collaborative
effort is necessary to effectively regulate gene therapy technologies. Other
national legislative bodies of work can be very influential in the development
of an international treaty such as China’s Civil Code182 and the UK’s Human
Fertilization and Embryology Act.183
This newly formed treaty will provide general guidelines for what a
violation of bioethical standards would look like. The treaty should set the
bare minimum of international expectations for ethics and safety procedures
of human genome technology. Should a nation think that additional
regulations are necessary, then a nation may develop stricter laws and
regulations with their own national legislature.

180. A Framework for Governance, supra note 97, at 49.
181. A Framework for Governance, supra note 97, at 49–55.
182. See Zhonghua Renmin Gongheguo Minfa Dian (中华人民共和国民法典) [Civil
Code of the People’s Republic of China] (promulgated by the Nat’l People’s Cong., May
28, 2020, effective Jan. 1, 2021), art. 1009, P.R.C. Laws.
183. LaTourelle, supra note 109.
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B. A New International Gene Editing Regulatory Agency
Should be Developed
The proposed international convention should develop a new agency to
regulate and enforce agreed upon bioethical genome experimentation
regulations. For the purpose of this paper, the organization will be called
the International Office of Genome Editing Regulation (“IOGER”). The
purpose of IOGER would be to allow scientific professionals a form of
“self-regulation,” which is something some scientist adamantly support.184
The organization’s board would be made up of scientific professionals,
high-ranking officials from other international organizations that have a
stake in this issue (WHO, UNESCO, WADA), and representatives from
other national governments. This combination of scientific and political
backgrounds could ensure that a scientific and political approach is taken
towards development of regulations, rather than an approach that overly
favors one side of the spectrum.
IOGER would achieve its goal of self-governance through an accreditation
system with a genome experiment registry such as the one currently being
developed by WHO.185 Likewise, it would use the international registry to
make sure all human genome experiments are known, thus preventing
situations like the Jiankui scandal.186 The agency would operate similar to
the Embryology Authority in the UK, with the authority to perform random
inspections for ongoing human genome experiments and license medical
centers as approved for human genome experiments.187
The accreditation process would be one of the most important functions
of IOGER. This organization would have an accreditation process for both
scientists and their labs before human genome experiments are allowed.
The license a scientist receives would be for a specific form of human
genome experiments (i.e., a researcher would have to specify what type
of experiment they wish to proceed with, whether it be germline or
somatic). The scientist would have to pass an ethical checklist created by
the international treaty, stating what the goal of their experiment is. All
scientists who get approved would have their research posted on the
international registry. This system would create transparency as to which
scientists have the proper licensing to perform gene therapy experiments
and which labs are properly set up for such.
184. Benjamin Hurlbut, Human Genome Editing: Ask Whether, Not How, 565 NATURE
135 (Jan. 2, 2019), https://www.nature.com/articles/d41586-018-07881-1 [https://perma.cc/
D46H-9BPA].
185. Call for Contribution, supra note 92.
186. CRISPR-Baby Prison Sentences, supra note 66.
187. How We Regulate, HUM. FERTILISATION & EMBRYOLOGY AUTH., https://www.
hfea.gov.uk/about-us/how-we-regulate/ [https://perma.cc/VS7D-5UUA].
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There is always the possibility that some will want to bypass these
regulations to pursue their own interests in genome experimentation; to
combat this possibility, the organization must attempt to incentivize
scientist to work within the ethical limits set by the international treaty.
Such limits could be achieved if IOGER developed their own scientific
journal where international human genome experiments are published.
IOGER could also develop their own International Summit on Human
Gene Editing to give scientist a platform to present their genome research,
like its current iteration run by the National Academy of Sciences,
National Academy of Medicine, Chinese Academy of Sciences, and the
Royal Society of the UK. 188 IOGER could restrict presentations at the
international summit to only researchers who have the proper licensing or
to scientist who have been published in their journal. IOGER’s journal
and summit would be the forefront reporting mechanism for human
genome researching while also providing IOGER the potential to raise
funds to further develop genome research infrastructure.
The goal of IOGER would be to implement the regulations decided
upon in the international treaty. IOGER would help promote safe and
ethical human genome experimentation through an accreditation process
and would incentive scientists to work within IOGER’s ethical boundaries
by providing a platform to present their studies. A journal and national
summit ran by IOGER would report the newest human genome editing
advances while also providing a source for IOGER to fundraise money to
help develop genome experiment infrastructure.
C. WADA Should Look Towards Implementing Genome
Screening by the 2028 Olympics
The most effective procedure in combatting gene doping appears to be
the detection method which monitors athlete’s genomes. IOGER could
help WADA maintain athlete genome records, as the new organization would
be equipped to handle this issue. Although the detection method might raise
issues related to genetic information, privacy, and discrimination, it is the
most effective and realistic modern detection method for gene doping.
188. It was at the Second International Summit on Human Genome Editing in HongKong where Jiankui presented his controversial experiment. Scientist Fails to Satisfy
Critics, supra note 69; International Summit on Human Gene Editing, NAT’L ACADS. OF
SCIS. ENG’G MED., https://www.nationalacademies.org/our-work/international-summiton-human-gene-editing [https://perma.cc/J6AC-CX4Y].
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WADA should look to implement a gene monitoring requirement as soon
as possible before gene doping becomes more of a reality to guarantee at
least some records of un-edited athlete genomes.
WADA should work with IOGER to maintain athletes’ genetic information.
IOGER would implement an international registry for Olympic athlete
genome monitoring purposes, but this is another type of registry that
would not be viewable to the general public so to maintain athlete genetic
privacy. WADA would receive athlete samples before international sporting
events, like the Olympics, and they would then archive the information
with IOGER. By the next time a tested athlete participates in an international
sporting event, WADA would be able to compare the athlete’s previous
genome with new samples from the athlete.
This type of testing would ensure that WADA does not create laboratory
standards for genetic markers related to athletic performance, as that type
of genome regulation could possibly see genetic discrimination liability.
WADA would only be looking for changes within an athlete’s genetic code.
It is important for this genome requirement to be added to WADA’s Athlete
Biological Passport soon so “clean” athlete genomes can be sequenced before
gene doping is attempted by an athlete. This method will not work if the
first sample collected by an athlete is already tainted by gene doping. Scientist
Lee Sweeney has stated:
If you are good enough in designing the gene doping, you may mimic what the
body normally does. Unless you longitudinally follow a person and have enough
early pre-doping data on them, you may not recognize that the person is anything
out of the ordinary other than a highly talented athlete.189

The current state of gene doping makes this detection method effective,
but additional detection tests will be necessary as gene doping technology
advances.
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Figure 1: Cost Per Genome Data190

WADA has previously considered sequencing athletes’ genomes but
ultimately decided against it due to the cost of genome sequencing at the
time.191 However, the price to sequence a genome has been dropping every
year, as illustrated in Figure 1. Although Figure 1 is a good visualization
of the drop in cost over time of sequencing a human genome, it is not
an accurate representation of large-scale application of this technology as
there are additional costs not included in the cost presented in Figure 1.192

190. Kris A. Wetterstrand, The Cost of Sequencing a Human Genome, NAT’L HUM.
GENOME RSCH. INST. (Dec. 7, 2020), https://www.genome.gov/about-genomics/fact-sheets/
Sequencing-Human-Genome-cost#:~:text=The%20estimated%20cost%20for%20
advancing,sequence%20is%20~%24150%20million%20worldwide [https://perma.cc/
Z8J9-D9FU].
191. Niiler, supra note 56.
192. Wetterstrand, supra note 190 (“These data, however, do not capture all of the
costs associated with the NHGRI Large-Scale Genome Sequencing Program. The sequencing
centers perform a number of additional activities whose costs are not appropriate to include
when calculating costs for production-oriented DNA sequencing.”).
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Even if sequencing athletes is a costly endeavor, it is surely worth it.
Beginning sequencing in 2028 would give WADA enough time to determine
the logistics of large-scale application. This might seem like a daunting
task for WADA to achieve alone, but collaboration with IOGER would
make this task much easier. IOGER would help develop the infrastructure
of research centers and sample storage using the funds generated by their
international journal and summit, while WADA would collect the samples
and process the results. WADA does not have many other options for detection
as their other methods are not yet ready to be implemented on a massive
scale.193
Another issue is how much of an athlete’s genome should be sequenced:
just the portions related to improvement of athletic performance or the
entire genome? The answer to this question will likely be based on the
logistical capacity of WADA and IOGER. By sequencing the entire genome
of an athlete, WADA and IOGER would have the most information to
observe and compare with. While several genes that relate to athletic
performance have been identified,194 there can still exist other unknown
enhancement genes. Some genes might work in conjunction with other
genes to improve athletic performance. The more information that WADA
can collect and observe, the higher the chances they would be able to
detect gene doping.
Although collecting larger portions of genomes would make more
forms of gene doping detectable, WADA’s “gene passport” program should
focus on collecting information known to be related to athletic performance.
Genetic privacy issues could possibly arise if WADA attempted to sequence
portions of the genome that have no relation to athletic performance. Other
than the genetic privacy issues, sequencing a whole genome would require
more work and would be more costly. It is a realistic goal for WADA and
IOGER to identify the genes most closely tied to athletic performance and
to then develop a system of monitoring these genes with athletes.
D. Punishment for Violations
The proposed treaty discussed in this paper should impose civil liability
in the form of fines, at the very least, to those who violate the regulations.
These fines would be reflective of the type of genome technology being
used with human germline experiments resulting in the highest fines. Civil
liability would provide for an international “floor” for human genome
regulations; national legislatures can develop their own criminal penalties
based off their constituents’ ethical views of genome editing.
193.
194.
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De Boer, supra note 62, at 345.
Wenner, supra note 38; Franks, supra note 43; Wang, supra note 50.
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It would be reasonable for other nations to adopt civil liability for
unethical human genome experiments as China has already done.195 This
treaty, if adopted by its signatories, would allow nations to fine those who
ignore or break the international regulations. These fines would make
more scientists respect the regulations as there would be a fiscal penalty
for not following the standards set in the treaty. Should a nation decide
that a particular form of human genome manipulation calls for criminal
liability, they are free to implement additional regulations through their
national legislature. The goal of this international agreement would be to
set international bioethical standards for human genome technologies; any
nations that wish to implement even stricter regulations are free to do so.
On top of civil liability, violations could also result in a “blacklist” ban
that would prevent scientists from working with human genome technology.
IOGER could maintain a “blacklist” for scientists who apply genome
technology in especially dangerous or unethical ways. Blacklisted scientists
would be prevented from receiving any licensing for subsequent human
genome experiments and would not be allowed to perform any research at
specially licensed human genome research centers. Blacklisted scientists
would also not be able to publish any of their findings in the IOGER
scientific journal, nor would they be allowed to present at the IOGER
International Summit on Human Gene Editing. These punishments, along
with civil fines and possible criminal liability depending on national
legislation where the experiment is performed, would likely be enough to
persuade researchers to follow the international guidelines.
While creating a punishment “floor” is important, it is more important
to promote safe testing and safe use of this technology. By promoting
testing reviewed through an ethical checklist, the concerns surrounding
the safe application of gene therapy can be alleviated. Once gene therapy
has made substantial progress towards becoming a truly safe and ethical
practice, it would be comparable to other medical procedures, like LASIK
eye surgery. By keeping the organizational focus on preventative actions
rather than retributive justice through harsh punishments, harm can be
prevented and there is less likely to be a negative effect on future research.196

195. Zhonghua Renmin Gongheguo Minfa Dian (中华人民共和国民法典) [Civil
Code of the People’s Republic of China] (promulgated by the Nat’l People’s Cong., May
28, 2020, effective Jan. 1, 2021), arts. 995, 1009, P.R.C. LAWS.
196. See CRISPR-Baby Prison Sentences, supra note 66.
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E. Regulations Reflecting Future Perspectives
Regulations agreed upon in the international treaty must be subject to
subsequent amendments to reflect changing public opinion. Gene editing
technology has great potential to address many untreatable medical illnesses;
improper regulations not subject to change would only prevent this
technology from reaching its full potential. None of the regulations should
deal in absolutes and the regulations should be subject to change at
subsequent conventions.
Although there is a current gene doping ban, future applications of
genome technology might not clearly fall in-between the spectrum of
“therapeutic use” vs “non-therapeutic” use. Sports medicine, a field that
could benefit from the application of safe gene therapy, is an example of
this grey area. Bioethicist Andy Miah explains, “[g]enetics offers the
possibility of allowing us to both repair but also enhance by using elements
that are already within our bodies.”197 How can a “therapeutic use” line be
drawn if gene edits have both therapeutic and performance enhancement
properties? This is an issue that WADA will face with its current gene
doping definition as gene therapy continues to progress. Several of the
current methods of possible gene doping were experiments that had
therapeutic value.198 Lee Sweeney has stated, “I think it’s unethical to
withhold from someone something that would actually allow their muscles
to be much healthier now and in the future.”199 The ban on gene doping is
proper right now, but it should be subject to change in the future to reflect
changing technological progress and changing public opinion.
Every fifteen-years, the convention should reconvene to decide if any
regulations should be changed. Gene technology raises plenty of ethical
issues, but future technological advances and societal progress might alleviate
these issues. Gene editing techniques will continue to evolve; previously
unthought of applications might raise new regulatory questions. It would
be improper to set strict, unmalleable regulations on this new evolving
technology. By requiring future meetings and continued conversation on
this topic, IOGER would ensure that international regulations will stay up
to date. This would make the regulations flexible enough to change with
public opinion and with changing gene editing techniques.

197. Nick Busca, Should Athletes Be Allowed to Enhance Their Genes?, ONEZERO
(Apr. 25, 2019), https://onezero.medium.com/should-athletes-be-allowed-to-enhancetheir-genes-c242dd007fa5 [https://perma.cc/J53E-W58B].
198. Wenner, supra note 38; Franks, supra note 43; Wang, supra note 50.
199. Le Page, supra note 169.
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VI. CONCLUSION
Gene doping, in its current iteration, is not safe and thus needs to be
regulated. WADA’s ban of gene doping was a first step to address this
issue, but a clearer and more nuanced approach must be taken with gene
technology. The unique pressure of international sports increases the
possibility that an athlete may eventually attempt this form of doping.
Genetic technology does not just impact international sports, so regulations
should be reflective of all the stakeholders involved in this issue. Clear
international standards can prevent future scandals in a way that also promotes
the safe and ethical progression of gene technologies. Ultimately, gene
doping needs clear regulations now while gene therapy techniques are still
considered dangerous, however, these regulations cannot be so harsh as
to limit the future potential of gene technologies.
As gene therapy continues to advance, it should be monitored how
international law advances with it. More research into genetic privacy law,
both at the international and national level, would be another area of
interest to analyze as gene editing evolves. More attention on human gene
technology will make people realize that time is not a luxury; human gene
editing will become a common scientific practice within the next 50 years
and the right regulations can create a positive future for this technology.
Society should not be fearful of the future of gene therapy. Instead, the
world should be excited for its potential. The desire for agencies and
governments to regulate this evolving field is understandable; gene therapy
is a powerful technology that could have devastating generational effects
if incorrectly used. While the consequences of failure are substantial, the
possible beneficial applications of this technology are equally considerable.
If it turns out that there are no safe gene editing technologies, then all
forms of gene therapy should be banned. If gene therapy can be performed
in a safe and ethical manner, then current regulations should be adjusted
to reflect the public opinion. Gene doping could allow displays of athletic
dominance reserved only to generational talents, and it could even have
the potential to help athletes recover from serious injuries quicker. Genome
technologies could advance sports medicine, and the world, to unbelievable
heights.
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